| Kaposi sarcoma E Cesarman, B Damania, SE Krown, J Martin, M Bower, D Whitby Nature reviews Disease primers 5 (1), 9, 2019 | 712 | 2019 |
| A trithorax–like gene is interrupted by chromosome 11q23 translocations in acute leukaemias M Djabali, L Selleri, P Parry, M Bower, BD Young, GA Evans Nature genetics 2 (2), 113-118, 1992 | 570 | 1992 |
| Association of prior antibiotic treatment with survival and response to immune checkpoint inhibitor therapy in patients with cancer DJ Pinato, S Howlett, D Ottaviani, H Urus, A Patel, T Mineo, C Brock, ... JAMA oncology 5 (12), 1774-1778, 2019 | 537 | 2019 |
| Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas M Cullen, N Steven, L Billingham, C Gaunt, M Hastings, P Simmonds, ... New England Journal of Medicine 353 (10), 988-998, 2005 | 490 | 2005 |
| Highly active antiretroviral therapy and the incidence of non–AIDS-defining cancers in people with HIV infection T Powles, D Robinson, J Stebbing, J Shamash, M Nelson, B Gazzard, ... Journal of Clinical Oncology 27 (6), 884-890, 2009 | 444 | 2009 |
| British HIV Association guidelines for the treatment of HIV‐1‐positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow … Writing Group, I Williams, D Churchill, J Anderson, M Boffito, M Bower, ... HIV medicine 15, 1-6, 2014 | 421 | 2014 |
| EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. M Bower, ES Newlands, L Holden, D Short, C Brock, GJ Rustin, ... Journal of Clinical Oncology 15 (7), 2636-2643, 1997 | 395 | 1997 |
| PD-L1 A Kythreotou, A Siddique, FA Mauri, M Bower, DJ Pinato Journal of clinical pathology 71 (3), 189-194, 2018 | 342 | 2018 |
| Phase I trial of temozolomide using an extended continuous oral schedule CS Brock, ES Newlands, SR Wedge, M Bower, H Evans, I Colquhoun, ... Cancer research 58 (19), 4363-4367, 1998 | 342 | 1998 |
| Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma M Bower, M Nelson, AM Young, C Thirlwell, T Newsom-Davis, S Mandalia, ... Journal of Clinical Oncology 23 (22), 5224-5228, 2005 | 336 | 2005 |
| Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy—results from an … K Fizazi, S Tjulandin, R Salvioni, JR Germą-Lluch, J Bouzy, D Ragan, ... Journal of clinical oncology 19 (10), 2647-2657, 2001 | 333 | 2001 |
| Fifty years of multicentric Castleman's disease A Waterston, M Bower Acta Oncologica 43 (8), 698-704, 2004 | 311 | 2004 |
| Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma M Bower, ES Newlands, NM Bleehen, M Brada, RJH Begent, H Calvert, ... Cancer chemotherapy and pharmacology 40, 484-488, 1997 | 290 | 1997 |
| A meta-analysis of transient elastography for the detection of hepatic fibrosis J Stebbing, L Farouk, G Panos, M Anderson, LR Jiao, S Mandalia, ... Journal of clinical gastroenterology 44 (3), 214-219, 2010 | 284 | 2010 |
| Changes in acquired immunodeficiency syndrome–related lymphoma since the introduction of highly active antiretroviral therapy GV Matthews, M Bower, S Mandalia, T Powles, MR Nelson, BG Gazzard Blood, The Journal of the American Society of Hematology 96 (8), 2730-2734, 2000 | 257 | 2000 |
| HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome? M Bower, T Powles, T Newsom-Davis, C Thirlwell, J Stebbing, S Mandalia, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 37 (5), 1563-1565, 2004 | 255 | 2004 |
| Brief communication: rituximab in HIV-associated multicentric Castleman disease M Bower, T Powles, S Williams, TN Davis, M Atkins, S Montoto, C Orkin, ... Annals of internal medicine 147 (12), 836-839, 2007 | 245 | 2007 |
| An open-label study of tenofovir in HIV-1 and hepatitis B virus co-infected individuals M Nelson, S Portsmouth, J Stebbing, M Atkins, A Barr, G Matthews, ... Aids 17 (1), F7-F10, 2003 | 232 | 2003 |
| AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy M Bower, C Palmieri, T Dhillon Current opinion in infectious diseases 19 (1), 14-19, 2006 | 226 | 2006 |
| Clinical features and outcome in HIV-associated multicentric Castleman's disease M Bower, T Newsom-Davis, K Naresh, S Merchant, B Lee, B Gazzard, ... Journal of Clinical Oncology 29 (18), 2481-2486, 2011 | 207 | 2011 |
